INOVIO to Present at Upcoming Investor Conferences in March
News provided by
Share this article
Share this article
PLYMOUTH MEETING, Pa., March 4, 2021 /PRNewswire/ INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced that Dr. J. Joseph Kim, President and CEO, along with other members of INOVIO management, will present at the following investor conferences in March:
H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Virtual 1x1 meetings only
Date: Thursday, March 18, 2021
Time: 10:40 a.m. ET
Presentation Format: Corporate Presentation
GTCR Announces Healthcare Partnership with Michael Mulhern and Phil Macnabb to Form Epselon Global
Experienced industry veterans once again partnering with GTCR to build market-leading healthcare business
News provided by
Share this article
Share this article
CHICAGO, March 4, 2021 /PRNewswire/ GTCR, a leading private equity firm, today announced that it has entered into a Leaders Strategy™ partnership with Michael Mulhern and Phil Macnabb to form Epselon Global, LLC ( Epselon Global ). Based in Chicago, IL, the new company will focus on acquiring companies and assets as part of a strategy to build a market-leading healthcare business.
GTCR, the firm that pioneered The Leaders Strategy™- finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth - will invest in Epselon Global from GTCR Fund XIII, a private equity fund with $7.5 billion of limited partner
Digital Pharmacist to offer free trial of its COVID-19 Vaccination Scheduler
Secure bulk and targeted text messaging to automate and streamline patient communications
Smartphone-based appointment check-ins for contactless care coordination
Efficient data capture and reporting
Explaining the importance of the company s solutions in the fight against COVID-19, Corey Hansen, CEO of Digital Pharmacist, commented, President Biden s Federal Retail Pharmacy Relief Program positions pharmacies on the frontline in the battle against COVID-19. Working in concert, our Vaccination Scheduler and Patient Engagement Platform will expand the reach of the President s program, enabling pharmacists and healthcare workers to efficiently administer millions of vaccinations.
his potential treatment opportunity was confirmed by the company s bioinformatics platform, PsyCollage
VANCOUVER, BC, March 4, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( MINDCURE or the Company ) a leader in developing technology to advance psychedelic-related treatments, is pleased to announce that the Company s bioinformatics platform,
PsyCollage, has identified opportunities for ibogaine to support neuroregenerative pathways that the Company believes could be pivotal in treating neuropathic pain and brain trauma.
Ibogaine is a psychoactive substance extracted from the iboga shrub native to West Africa. Contributing to its powerful anti-addiction actions, ibogaine is associated with increases in the levels of brain neurotrophic factors, particularly GDNF and BDNF, which have potent neuroregenerative and neuroprotective properties.
/PRNewswire/ Cano Health, LLC ("Cano Health" or the "Company"), a leading value-based primary care delivery platform for seniors, today announced that a.